Atherosclerosis in hemodialysis patients: Traditional and nontraditional risk factors

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 15, Issue 4, 2006, Pages 151-157

  Bevc, Sebastjan ^a   Hojs, Radovan ^a   Ekart, Robert ^a   Hojs Fabjan, Tanja ^a  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

Author keywords

Atherosclerosis; Carotid arteries; Hemodialysis; Intima media thickness; Plaques; Risk factors; Ultrasound

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; B SCAN; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INTIMA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE FACTORS; AGED; APOLIPOPROTEINS B; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; CHOLESTEROL; CORONARY DISEASE; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENAL DIALYSIS; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 33846147645     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000; 35: Suppl 1: S117-31.
2. Culleton BF, Wilson PWF. Cardiovascular disease: risk factors, secular trends and therapeutic guidelines. J Am Soc Nephrol 1998; 9: 5-15.
3. London GM, Drüeke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 1997; 51: 1678-95.
4. Kawagishi T, Nishizawa Y, Konishi T et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 1995; 48: 820-6.
5. Hojs R. Carotid intima-media thickness and plaques in hemodialysis patients. Artif Organs 2000; 9: 691-5.
6. Savage T, Clarke AL, Giles M, Tomson CRV, Raine AEG. Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease. Nephrol Dial Transplant 1998; 13: 2004-12.
7. London GM, Guërin AP, Marchais SJ et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996; 50: 600-8.
8. Pascazio L, Bianco F, Giorgini A, Galli G, Curri G, Panzetta G. Echo color Doppler imaging of carotid vessels in hemodialysis patients: evidence of high levels of atherosclerotic lesions. Am J Kidney Dis 1996; 28: 713-20.
9. Craven TE, Ryu JE, Espeland MA et al. Evaluation of the association between carotid artery atherosclerosis and coronary artery stenosis: a case control study. Circulation 1990; 82: 1230-42.
10. Salonen R, Seppanen K, Rauramaa R, Salonen JT. Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland. Arteriosclerosis 1988; 8: 788-92.
11. Burdick, L, Periti M, Salvaggio A et al. Relation between carotid artery atherosclerosis and time on dialysis. A non-invasive study. Clin Nephrol 1994; 42: 121-6.
12. Bonithon Kopp C, Touboul PJ, Berr C, Leroux C, Mainard F, Courbon D, Ducimetiere P. Relation of intima-media thickness to atherosclerotic plaques in carotid arteries. The Vascular Aging (EVA) Study. Arterioscler Thromb Vasc Biol 1996; 16: 310-6.
13. Stempfer MJ, Malinow MR. Can lowering homocysteine levels reduces cardiovascular risk? N Engl J Med 1995; 332: 328-9.
14. Stempfer MJ, Malinow MR, Willett WC et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. J Am Med Assoc 1992; 268: 877-81.
15. Docci D, Manzoni G, Bilancioni R et al. Serum lipoprotein (a) and coronary artery disease in uremic patients on chronic hemodialysis. Int J Artif Organs 1994; 17: 41-5.
16. Del Cura J, Gil-Paraiso A, Borqe L, Carazo ME, Maside C, Sanchez-Casajus A. Serum lipoprotein (a) in chronic renal failure patients undergoing hemodialysis: does it have an independent role in the development of further cardiovascular complication? Nephron 1993; 65: 644-5.
17. Persson J, Formgren J, Israelsson B, Berglund G. Ultrasound Determined Intima-Media Thickness and Atherosclerosis. Direct and Indirect Validation. Arterioscler Thromb 1994; 14: 261-4.
18. Grobbee DE, Bots ML. Carotid artery intima-media thickness as an indicator of generalized atherosclerosis. J Intern Med 1994; 236: 567-73.
19. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal failure. J Am Soc Nephrol 1998;32 (Suppl 4): 16-23.
20. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10: 1606-15.
21. Hojs R, Hojs-Fabjan T, Pečovnik-Balon B. Atherosclerosis in patients with end-stage renal failure prior to initiation of hemodialysis. Ren Fail 2003; 25: 247-54.
22. Charra B, Calemard E, Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 1996; 16: 35-44.
23. Nakashima A, Yorioka N, Asakimori Y, Ito T, Masaki T, Shigemoto K, Harada S. Different risk factors for the maximum and the mean carotid intima-media thickness in hemodialysis patients. Intern Med 2003; 42: 1095-9.
24. Benedetto FA, Mallamaci F, Tripepi G, Zoccali C. Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol 2001; 12: 2458-64.
25. Kato A, Takita T, Maruyama Y, Kumagai H, Hishida A. Impact of carotid atherosclerosis on long-term mortality in chronic hemodialysis patients. Kidney Int 2003; 64: 1472-9.
26. Hojs R, Hojs-Fabjan T, Pečovnik-Balon B. Atherosclerosis and risk factors in non-diabetic hemodialysis patients. Dial Transplant 2004; 10: 624-33.
27. Libetta C, Villa G, Pirrelli S et al. Homocysteine plasma levels correlate with intimal carotid artery thickness in haemodialysis patients. Nephrol Dial Transplant 2001; 16: 2444-5.
28. Zoccali C, Benedetto FA, Mallamaci F et al. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens 2000; 18: 1207-13.
29. Kato A, Takita T, Maruyama Y, Kumagai H, Hishida A. Impact of carotid atherosclerosis on long-term mortality in chronic hemodialysis patients. Kidney Int 2003; 64: 1472-9.
30. Brzosko S, Lebkowska U, Malyszko J, Hryszko T, Krauze-Brzosko K, Mysliwiec M. Intima media thickness of common carotid arteries is associated with traditional risk factors and presence of ischaemic heart disease in hemodialysis patients. Physiol Res 2005; 54: 497-504.
31. Kronenberg F, Neyer U, Lhotta K et al. The low molecular weight apo (a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: prospective follow up. J Am Soc Nephrol 1999; 10: 1027-36.
32. Koch M, Kutkuhn B, Trenkwalder E et al. Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein (a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol 1997; 8: 1889-98.
33. Kronenberg F, Kathrein H, König P et al. Apolipoprotein (a) phenotypes predict the risk of carotid atherosclerosis in patients with end-stage renal disease. Arterioscler Thromb 1994; 14: 1405-11.
34. Kwiterovich PO Jr, Coresh J, Smith HH, Bachorik PS, Derby CA, Pearson TA. Comparison of the plasma levels of apolipoproteins B and A1, and other risk factors in men and women with premature coronary artery disease. Am J Cardiol 1992; 69: 1015-21.
35. Muntner P, Hamm LL, Kusek JW, Chen J, Wheton PK, He J. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 2004; 140: 9-17.